Researcher says engineered avian influenza virus isn't lethal

01/25/2012 | Bloomberg

The airborne version of highly pathogenic avian influenza strain H5N1 engineered at the University of Wisconsin at Madison is not fatal and can be treated by currently available medicines, said Yoshihiro Kawaoka, professor of virology and the study's lead researcher. Kawaoka halted his research following an agreement reached with federal officials over bioterrorism concerns related to the altered virus, but he argues that more research is urgently needed.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC